Fibroblast growth factor 21 is elevated in metabolically unhealthy obesity and affects lipid deposition, adipogenesis, and adipokine secretion of human abdominal subcutaneous adipocytes-Reference-Cited by-同舟云学术

Fibroblast growth factor 21 is elevated in metabolically unhealthy obesity and affects lipid deposition, adipogenesis, and adipokine secretion of human abdominal subcutaneous adipocytes

Published:2015-07 Issue:7 Volume:4 Page:519-527
ISSN:2212-8778
Container-title:Molecular Metabolism
language:en
Short-container-title:Molecular Metabolism

Author:

Berti Lucia,Irmler Martin,Zdichavsky Marty,Meile Tobias,Böhm Anja,Stefan Norbert,Fritsche Andreas,Beckers Johannes,Königsrainer Alfred,Häring Hans-Ulrich,de Angelis Martin Hrabě,Staiger Harald

Funder

Ministry of Education

Helmholtz Portfolio Theme

Helmholtz Alliance ‘ICEMED’

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology

Reference44 articles.

1. Circulating fibroblast growth factors as metabolic regulators–a critical appraisal;Angelin;Cell Metabolism,2012

2. Biological role, clinical significance, and therapeutic possibilities of the recently discovered metabolic hormone fibroblastic growth factor 21;Iglesias;European Journal of Endocrinology,2012

3. FGF-21 as a novel metabolic regulator;Kharitonenkov;Journal of Clinical Investigation,2005